Brief: Biomed-Lublin Q1 Net Result Turns To Loss Of 1.2 Mln Zlotys

Synthaverse SA

28/05/2021 06:31

May 28 (Reuters) - Biomed-Lublin Wytwórnia Surowic i
Szczepionek SA  BML.WA :
    * REPORTED ON THURSDAY Q1 NET LOSS 1.2 MILLION ZLOTYS VERSUS
PROFIT OF 1.1 MILLION ZLOTYS YR AGO
    * Q1 REVENUE 5.6 MILLION ZLOTYS VERSUS 10.4 MILLION ZLOTYS
YEAR
AGO
    * Q1 OPERATING LOSS 0.8 MILLION ZLOTYS VERSUS PROFIT OF 2.3
MILLION ZLOTYS YEAR AGO
    * Q1 EBITDA 0.7 MILLION ZLOTYS VERSUS 3.8 MILLION ZLOTYS
YEAR AGO
    * DROP IN MAIN OPERATING PARAMETERS WAS DUE TO SHIFTING
PRODUCTION
OF SOME PRODUCTS TO SUBSEQUENT QUARTERS AS AWELL AS NEED TO
MANAGE SUPPLY CHAIN DISRUPTIONS DURING THIRD WAVE OF CORONAVIRUS
PANDEMIC
    * PRODUCTION SHIFTS WILL SIGNIFICANTLY INCREASE RESULTS IN
SUBSEQUENT QUARTERS

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM3Nx8vDa
    
 Further company coverage:  BML.WA  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))